Verdezyne Signs Distribution Agreement with Connell Bros.

CARLSBAD & SAN FRANCISCO, Ca., Mar 9, 2016 - (ACN Newswire) - Verdezyne, Inc., a synthetic biology company producing biobased chemicals, and Connell Bros. Co. LLC (CBC), the largest marketer and distributor of specialty chemicals in the Asia-Pacific region, announced an agreement for sales and distribution of Verdezyne's BIOLON(TM) DDDA (biobased dodecanedioic acid or "DC12"). BIOLON(TM) DDDA will be produced at Verdezyne's commercial-scale plant in Malaysia and will be distributed in 17 countries throughout Asia-Pacific, including China, Japan and South Korea. The agreement assures CBC of access to more than 10% of the expected plant capacity.Verdezyne's BIOLON(TM) DDDA is produced more sustainably than traditional petroleum-derived intermediate chemicals and will be used to make a variety of end-user products including automotive parts, toothbrush bristles, cosmetics, and fragrances."This agreement with CBC reflects the strong interest in high quality renewable chemicals such as our BIOLON(TM) DDDA," said E. William Radany, Ph.D., president and CEO of Verdezyne. "As one of the largest and most respected distributors of specialty chemicals in the Asia-Pacific region, CBC is a strong partner for us. We are sure this agreement marks the beginning of a long and mutually-beneficial relationship." Verdezyne's plant, expected to be completed in 2017, is anticipated to have the capacity to produce up to 9,000 metric tons of diacids including BIOLON(TM) DDDA annually. "Verdezyne presented us with a very strong value proposition," commented Scott Graddy, vice president, CBC. "We anticipate a strong demand for BIOLON(TM) DDDA from our customers in Asia-Pacific. We are very pleased to have reached this agreement with Verdezyne and we look forward to distributing BIOLON(TM) DDDA throughout the region."For samples, orders or more information about Verdezyne's BIOLON(TM) DDDA, please contact:Asia: [email protected]Worldwide: [email protected]About VerdezyneVerdezyne is a synthetic biology company offering biobased chemicals developed using proprietary metabolic pathway engineering tools. The company's first product, BIOLON(TM) DDDA, earned the USDA Certified Biobased Product label, and is available worldwide. Current investors in Verdezyne include BP Ventures, DSM Venturing B.V., OVP Venture Partners, Monitor Ventures, and Sime Darby. For more information, visit www.verdezyne.com or connect with the company on Twitter, LinkedIn or Facebook.About Connell Bros. Co.Founded in 1895, Connell Bros. Co. LLC is one of the Wilbur-Ellis family of companies and is the largest marketer and distributor of specialty chemicals and ingredients in Asia-Pacific with a keen focus on technical service, customer support, and environmental, health, and safety. Connell Brothers provides complete supply chain management from transportation, documentation, warehousing, and sales and distribution in 17 countries and in 47 offices located throughout Asia-Pacific. For more information, please visit www.connellbrothers.com.Contact:

Verdezyne Media Contacts:

Aida Yodites
Corporate Comms, Verdezyne, Inc.
+1(760)707-5200
[email protected]

Bill Douglass
Sparkpr
+1(646)504-0890
[email protected]

Connell Bros Co Media Contact:

Mandy Weih
Marcomms, CBC Hong Kong
+852-2969-2730
[email protected]

Copyright 2016 ACN Newswire . All rights reserved.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• RS names Nisha Brown VP of marketing for the Americas region
• InnoCare Announces Approval of Head-to-Head Registrational Phase III Trial of Mesutoclax with Azacitidine versus Venetoclax with Azacitidine in Treatment-Naive AML in China
• $COOPER Announces Community-Building Initiative Within the Robinhood Chain Ecosystem